This is an overview of the USAID/India FY 2021 Tuberculosis (TB) Roadmap, implemented with FY 2020 budget.

TABLES

The following tables illustrate the distribution by technical area of the USAID TB budget for India that will be used for the implementation of India’s FY21 TB Roadmap (Table 1) and the core indicators that will be used to monitor implementation of India’s TB Roadmap and the country's progress towards the United Nations General Assembly High-Level Meeting on TB targets (UNGA targets) (Table 2).

Table 1: USAID Budget for India per Technical Area*

Technical AreaUSAID TB budget for FY21USAID Percentage of TB budget for FY21
REACH$9,145,00048%
CURE$6,811,00036%
PREVENT$1,734,0009%
SELF-RELIANCE$1,294,0007%
TOTAL BUDGET:$18,984,000100%

*USAID is working with the Global Fund to provide similar budget data for next year. It is anticipated this information will be added once the discussions have been finalized.


Table 2: TB Core Indicators in India from 2015-2019 and Targets from 2020-2022

#Name201520162017201820192020*2021*2022*
REACH: Increased DS- and DR-TB case notification
1TB Detection58.7%63.2%60.2%74.1%82%UNGA Target: 2,404,900UNGA Target: 2,245,600UNGA Target: 2,092,600
2Bacteriological Diagnosis Coverage (Pulmonary TB)63.9%62.6%71.1%56.7%57.0%
3Childhood TB Notifications99,133104,886101,170129,510145,574UNGA target: 251,900UNGA target: 271,000UNGA target: 265,800
4Drug-Resistant TB Notifications31,92439,72241,65961,74768,578UNGA target: 86,070UNGA target: 110,210UNGA target: 124,050
5Private Sector TB NotificationsTBDTBDTBD542,527678,895
6Contact Investigation Coverage**TBDTBDTBDTBD79.0%
CURE: High treatment success rate in DS- and DR-TB
7TB Treatment Success Rate85.1%85.8%84.7%91%**
8Drug-Resistant TB treatment Success Rate46.9%47.1%48%
PREVENT: Prevent TB transmission and development
9TPT Coverage59187713,76121,841973,171UNGA target: 1,225,430UNGA target: 1,867,020UNGA target: 2,252,910
SELF-RELIANCE: Commitment and sustainability
10Proportion of Domestic Financing for TB68.0%85%

*Projected UNGA targets.
***TB Treatment Success Rate is calculated among the 2018 cohort, after the exclusion of those who have not been evaluated.